M. Oort

530 citations
10 papers · 412 indexed · h-index 8

M. Oort

10 papers receiving 357 citations

Peers

M. Oort
Comparison fields: 5 of 64
  • Genetics 125
  • Biochemistry 51
  • Hematology 71
  • Pediatrics, Perinatology and Child Health 80
  • Physiology 90
Replace Anton J. Aarsman with:
Anton J. Aarsman Netherlands
V Brabec Czechia
Colette Galand France
R. Pflugshaupt Switzerland
Nicole J. Croteau United States
M. García‐Delgado Spain
Christopher J. Mariani United States
Anne Janin France
Yasuhiro Yamashiro Japan
M. Marini Italy
M. Oort relative to Anton J. Aarsman Netherlands Anton J. Aarsman's profile →
Citations per field
00.5×3.2×
Anton J. Aarsman · 1×
Citations per year

Countries citing papers authored by M. Oort

Since Specialization
Citations

This map shows the geographic impact of M. Oort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Oort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Oort more than expected).

Fields of papers citing papers by M. Oort

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Oort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Oort. The network helps show where M. Oort may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M. Oort, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Oort Line = papers co-authored together M. Oort links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 201323
2 201015
3 20099
4 200447
5
[Hemolytic disease of the newborn and chronic hypochromic microcytic anemia in one family: gamma-delta-beta thalassemia].
19811
6
Haemolytic disease of the newborn and chronic anaemia induced by gamma beta thalassaemia in a Dutch family.
19817
7 1980152
8 196680
9
[Enzyme deficiency in the erythrocytes and hemolytic anemia].
19621
10 196177

About M. Oort

M. Oort is a scholar working on Genetics, Physiology and Pharmacy, having authored 10 papers that have together received 412 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Neonatal Health and Biochemistry (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Pancreatic function and diabetes (2 papers), Adenosine and Purinergic Signaling (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Genetics (125 citations), Biochemistry (51 citations) and Hematology (71 citations). M. Oort has collaborated with scholars based in Netherlands, China and Canada. Frequent co-authors include J.A. Loos, H. K. Prins, Dirk Roos, Luigi F. Bernini, Richard A. Flavell, L. H. T. Van der Ploeg, Thomas Beckers, C. Zurcher, Roderick H.J. Houwen and Ruud Berger. Their work appears in journals such as Archives of Physiology and Biochemistry, Blood, Nature, Vox Sanguinis and Biological Trace Element Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026